Clinical Trial Update: Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a therapy for relapsed or refractory non-Hodgkin lymphoma is currently recruiting. Sponsored by ImmunityBio, Inc., the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Non-Hodgkin Lymphoma Refractory/ Relapsed | Phase 1 | Status: RECRUITING